182 related articles for article (PubMed ID: 1963411)
21. Pulmonary disposition of erythromycin, azithromycin, and clarithromycin in foals.
Suarez-Mier G; Giguère S; Lee EA
J Vet Pharmacol Ther; 2007 Apr; 30(2):109-15. PubMed ID: 17348895
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of lung tissue and hilar lymph node concentrations of azithromycin.
Cazzola M; Siniscalchi C; Vinciguerra A; Santangelo G; Matera MG; Rossi F
Int J Clin Pharmacol Ther; 1994 Feb; 32(2):88-91. PubMed ID: 8004364
[TBL] [Abstract][Full Text] [Related]
23. Distribution characteristics of orally administered olamufloxacin, a newly synthesized fluoroquinolone antibacterial, in lung epithelial lining fluid and alveolar macrophage in rats.
Sun J; Deguchi Y; Tauchi Y; He Z; Cheng G; Morimoto K
Eur J Pharm Biopharm; 2006 Oct; 64(2):238-45. PubMed ID: 16875808
[TBL] [Abstract][Full Text] [Related]
24. Comparative penetration of selected fluoroquinolones into respiratory tract fluids and tissues.
Wise R
Am J Med; 1991 Dec; 91(6A):67S-70S. PubMed ID: 1662897
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary penetration of ceftazidime.
Cazzola M; Gabriella Matera M; Polverino M; Santangelo G; De Franchis I; Rossi F
J Chemother; 1995 Feb; 7(1):50-4. PubMed ID: 7629560
[TBL] [Abstract][Full Text] [Related]
26. The penetration of rufloxacin into sites of potential infection in the respiratory tract.
Wise R; Andrews J; Imbimbo BP; Greaves I; Honeybourne D
J Antimicrob Chemother; 1993 Dec; 32(6):861-6. PubMed ID: 8144426
[TBL] [Abstract][Full Text] [Related]
27. Azithromycin concentrations in sinus fluid and mucosa after oral administration.
Karma P; Pukander J; Penttilä M
Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):856-9. PubMed ID: 1662632
[TBL] [Abstract][Full Text] [Related]
28. Azithromycin--spectrum of activity, pharmacokinetics, and clinical applications.
Drew RH; Gallis HA
Pharmacotherapy; 1992; 12(3):161-73. PubMed ID: 1319048
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary disposition of lomefloxacin in patients with acute exacerbation of chronic obstructive pulmonary disease. A multiple-dose study.
Cazzola M; Matera MG; Tufano MA; Catalanotti P; Polverino M; Cantoni V; Fici F; Sarlo F; Rossi F
J Chemother; 2001 Aug; 13(4):407-12. PubMed ID: 11589484
[TBL] [Abstract][Full Text] [Related]
30. Concentrations of OPC-17116, a new fluoroquinolone antibacterial, in serum and lung compartments.
Cook PJ; Andrews JM; Wise R; Honeybourne D; Moudgil H
J Antimicrob Chemother; 1995 Feb; 35(2):317-26. PubMed ID: 7759395
[TBL] [Abstract][Full Text] [Related]
31. Concentration of amoxycillin and clavulanate in lung compartments in adults without pulmonary infection.
Cook PJ; Andrews JM; Woodcock J; Wise R; Honeybourne D
Thorax; 1994 Nov; 49(11):1134-8. PubMed ID: 7831630
[TBL] [Abstract][Full Text] [Related]
32. High and prolonged pulmonary tissue concentrations of azithromycin following a single oral dose.
Morris DL; De Souza A; Jones JA; Morgan WE
Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):859-61. PubMed ID: 1662633
[TBL] [Abstract][Full Text] [Related]
33. Rifampicin concentrations in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum following a single 600 mg oral dose in patients undergoing fibre-optic bronchoscopy.
Ziglam HM; Baldwin DR; Daniels I; Andrew JM; Finch RG
J Antimicrob Chemother; 2002 Dec; 50(6):1011-5. PubMed ID: 12461025
[TBL] [Abstract][Full Text] [Related]
34. The concentrations of clinafloxacin in alveolar macrophages, epithelial lining fluid, bronchial mucosa and serum after administration of single 200 mg oral doses to patients undergoing fibre-optic bronchoscopy.
Honeybourne D; Andrews JM; Cunningham B; Jevons G; Wise R
J Antimicrob Chemother; 1999 Jan; 43(1):153-5. PubMed ID: 10381116
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary concentrations of dirithromycin and erythromycin during acute exacerbation of mild chronic obstructive pulmonary disease.
Matera MG; Tufano MA; Polverino M; Rossi F; Cazzola M
Eur Respir J; 1997 Jan; 10(1):98-103. PubMed ID: 9032500
[TBL] [Abstract][Full Text] [Related]
36. Function of human alveolar macrophages after a 3-day course of azithromycin in healthy volunteers.
Aubert JD; Juillerat-Jeanneret L; Fioroni P; Dayer P; Plan PA; Leuenberger P
Pulm Pharmacol Ther; 1998; 11(4):263-9. PubMed ID: 10101742
[TBL] [Abstract][Full Text] [Related]
37. Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin.
Conte JE; Golden JA; Duncan S; McKenna E; Zurlinden E
Antimicrob Agents Chemother; 1995 Feb; 39(2):334-8. PubMed ID: 7726492
[TBL] [Abstract][Full Text] [Related]
38. Concentrations of garenoxacin in plasma, bronchial mucosa, alveolar macrophages and epithelial lining fluid following a single oral 600 mg dose in healthy adult subjects.
Andrews J; Honeybourne D; Jevons G; Boyce M; Wise R; Bello A; Gajjar D
J Antimicrob Chemother; 2003 Mar; 51(3):727-30. PubMed ID: 12615879
[TBL] [Abstract][Full Text] [Related]
39. Serum, sputum and bronchial concentrations of erythromycin in chronic bronchitis after single and multiple treatments with either propionate-N-acetylcysteinate or stearate erythromycin.
Ricevuti G; Pasotti D; Mazzone A; Gazzani G; Fregnan GB
Chemotherapy; 1988; 34(5):374-9. PubMed ID: 3180905
[TBL] [Abstract][Full Text] [Related]
40. Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients.
Lamer C; de Beco V; Soler P; Calvat S; Fagon JY; Dombret MC; Farinotti R; Chastre J; Gibert C
Antimicrob Agents Chemother; 1993 Feb; 37(2):281-6. PubMed ID: 8452359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
